Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by kaosblueson Feb 02, 2012 12:38pm
263 Views
Post# 19480354

RE: RE: RE: RE: RE: End of January now!!!

RE: RE: RE: RE: RE: End of January now!!!

What a pile of suckee slurpee nervous nellies.  The promised 43's are two days overdue not 200, according to their estimates.   Show a little patience and some backboneand some of you investors need to remember the platinum rule:  for every buyer there is a seller.  So if you believe the seller knows something then is it not equally true that the buyer does too?   Besides, it looks like the SP is trending up. Overdue by two days on this is about the equivalent of being 30 seconds late for a meeting; and I might add a meeting that didn't have a specific time.  Towards the end of January leaves open the possibility of into February.  I think those that are being so literal about "the end of January" meaning Januray 31 are simply ANAL.  Chill out...

Give Bill a bit of credit, he will come forward with this information in due course, and probably with good timing.  I guess what I am saying is please quit being like a bunch of spoiled brats asking repeatedly:  Are we there yet?

Bullboard Posts